{"id":6157,"date":"2026-04-21T14:40:14","date_gmt":"2026-04-21T12:40:14","guid":{"rendered":"https:\/\/www.neftys-pharma.com\/for-talents-entre-au-capital-de-neftys-pharma\/"},"modified":"2026-04-23T12:41:47","modified_gmt":"2026-04-23T10:41:47","slug":"for-talents-entre-au-capital-de-neftys-pharma","status":"publish","type":"post","link":"https:\/\/www.neftys-pharma.com\/en\/for-talents-entre-au-capital-de-neftys-pharma\/","title":{"rendered":"For Talents Joins Neftys Pharma’s Capital"},"content":{"rendered":"\n

For Talents joins GENEO Capital Entrepreneur and UI Investissement as a shareholder in Neftys Pharma to support the family’s generational handover and accelerate the group’s growth strategy.<\/strong> <\/strong><\/h2>\n\n\n\n
<\/div>\n\n\n\n

Neftys Pharma, a leading French distributor of animal health products (730 employees, \u20ac555 million in revenue in 2025), is welcoming For Talents to its shareholder base alongside GENEO Capital Entrepreneur and UI Investissement, both of which are reinvesting in this new financing round to support the family’s generational handover and the company’s development, particularly internationally.<\/strong> <\/p>\n\n\n\n

<\/div>\n\n\n\n

For Talents’ investment forms part of the handover from Jacques Mignot, the group’s founder, to his son Diego Mignot, currently Chief Executive Officer, who will become Chairman on May 1. He will succeed his father in that role.<\/p>\n\n\n\n

<\/div>\n\n\n\n
\n
\n
\n
<\/div>\n\n\n\n

Alongside the Mignot family, For Talents, a family-capital investment company whose mission is to increase the success rate of generational handovers in family businesses, is taking a minority stake to support this new structuring phase for the group, combining investment with tailored support for leaders navigating succession.<\/p>\n\n\n\n

<\/div>\n\n\n\n

For their part, UI Investissement and GENEO Capital Entrepreneur, already minority shareholders for the past four years, are reinvesting and reaffirming their support for a project now even more strongly focused on international expansion, notably through the implementation of GENEO’s tailored growth playbook. This new investment reflects their confidence in Neftys Pharma’s strategy and management team.<\/p>\n<\/div>\n\n\n\n

\n
\"Jacques<\/figure><\/div><\/div>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n\n\n\n

A family handover prepared in continuity with the entrepreneurial vision<\/strong><\/strong><\/h2>\n\n\n\n
<\/div>\n\n\n\n

Founded in 1987 by Jacques Mignot, Neftys Pharma has grown on the conviction that distribution plays a central role in creating value in the animal health market. Today, the group is reaching a new milestone with the transfer to the second generation.<\/p>\n\n\n\n

This transition has been designed to ensure continuity of the family-led project while strengthening governance and equipping the group to deliver on its future ambitions, particularly internationally.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Neftys Pharma, a key actor across the animal health value chain<\/strong><\/strong><\/h2>\n\n\n\n
<\/div>\n\n\n\n

Neftys Pharma has established itself as a strategic partner to laboratories and animal health professionals.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Building on its longstanding logistics expertise, the group has gradually expanded its scope to become a comprehensive distribution platform capable of meeting the needs of all its partners.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Today, Neftys Pharma offers a full range of services spanning the entire value chain: logistics, marketing, data, digital, and strategic support for laboratories in accessing the market. Through this integrated approach, the group works every day to help ensure access to animal health solutions for professionals and animal owners.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Present in 8 countries in Europe (France, Portugal, Spain, Belgium, Poland, Croatia, Serbia and Slovenia) and 7 in Africa (Morocco, Senegal, C\u00f4te d’Ivoire, Nigeria, Burkina Faso, Niger and Mauritius), the group is pursuing an active growth strategy, illustrated by several acquisitions completed in recent years that have strengthened both its geographic footprint and its local positions.<\/p>\n\n\n\n

<\/div>\n\n\n\n

Neftys Pharma aims to accelerate both organic and external growth through five major levers:<\/strong><\/strong><\/p>\n\n\n\n

<\/div>\n\n\n\n